Voyager Therapeutics (VYGR) EPS (Diluted) Growth (1y) (2019 - 2026)
Voyager Therapeutics (VYGR) EPS (Diluted) Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 17,091.12% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 61.58% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -7.16% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 114.31% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Voyager Therapeutics | 184.74 Mn | 43.26 Mn | - | 11.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.68% |
| Dec 31, 2025 | 21.86% |
| Sep 30, 2025 | -203.41% |
| Jun 30, 2025 | -223.88% |
| Mar 31, 2025 | -168.01% |
| Dec 31, 2024 | -147.26% |
| Sep 30, 2024 | 73.52% |
| Jun 30, 2024 | 65.57% |
| Mar 31, 2024 | -106.74% |
| Dec 31, 2023 | 305.43% |
| Sep 30, 2023 | -232.58% |
| Jun 30, 2023 | -2.39% |
| Mar 31, 2023 | 625.10% |
| Dec 31, 2022 | -506.42% |
| Sep 30, 2022 | 166.94% |
| Jun 30, 2022 | 56.15% |
| Mar 31, 2022 | 75.95% |
| Dec 31, 2021 | 135.54% |
| Sep 30, 2021 | -129.28% |
| Jun 30, 2021 | -115.80% |